๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy of postoperative adjuvant therapy for stage ilia breast cancer: Futraful vs futraful+tamoxifen for er-positive patients and futraful vs futraful + adriamycin for er-negative breast cancer

โœ Scribed by Minoru Yoshida; Osahiko Abe; Junichi Uchino; Kaneo Kikuchi; Rikiya Abe; Kohji Enomoto; Takeshi Tominaga; Atsuo Fukami; Katsuharu Sakai; Hiroki Koyama; Keizo Sugimachi; Asuo Nomura; Takao Hattori; Nobuya Ogawa

Publisher
Springer Japan
Year
1997
Tongue
English
Weight
854 KB
Volume
4
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Adjuvant six cycles of high-dose adriamy
Adjuvant six cycles of high-dose adriamycin, cyclophosphamide, methotrexate, 5-fluorouracil (ACMF) vs. 12 cycles of low-dose acmf with tamoxifen for premenopausal, node-positive breast cancer patients: Results of a prospective randomized study
โœ Dr. Takashi Fukutomi; Sadako Akashi; Takeshi Nanasawa; Hiroshi Yamamoto ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 398 KB

A prospective randomized study was conducted to compare the adjuvant efficacy of six cycles of high-dose ACMF (Adriamycin, ADM; cyclophosphamide, CPA; methotrexate, MTX; 5-fluorouracil, 5-FU) with that of 12 cycles of low-dose ACMF in premenopausal, node-positive breast cancer patients. The six-cycl